Apart from oncogenic ubiquitin E3 ligases, the tumorigenic capacities of several ubiquitin-conjugating enzymes (E2) also promote proteasomal degradation of p53, particularly in HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.